Fingerprint
Dive into the research topics of 'Olaparib combined with an ATR or Chk1 inhibitor as a treatment strategy for acquired olaparib-resistant BRCA1 mutant ovarian cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Olaparib combined with an ATR or Chk1 inhibitor as a treatment strategy for acquired olaparib-resistant BRCA1 mutant ovarian cells
Brian T. Burgess, Abigail M. Anderson, J. Robert McCorkle, Jianrong Wu, Frederick R. Ueland, Jill M. Kolesar
Research output: Contribution to journal › Article › peer-review
40
Scopus
citations